AKESF
Price
$12.10
Change
+$0.38 (+3.24%)
Updated
Jul 1 closing price
Capitalization
10.51B
SMMT
Price
$22.66
Change
+$1.46 (+6.89%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
15.81B
35 days until earnings call
Interact to see
Advertisement

AKESF vs SMMT

Header iconAKESF vs SMMT Comparison
Open Charts AKESF vs SMMTBanner chart's image
AKESO
Price$12.10
Change+$0.38 (+3.24%)
Volume$890
Capitalization10.51B
Summit Therapeutics
Price$22.66
Change+$1.46 (+6.89%)
Volume$109.68K
Capitalization15.81B
AKESF vs SMMT Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. SMMT commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and SMMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (AKESF: $12.10 vs. SMMT: $21.20)
Brand notoriety: AKESF and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 22% vs. SMMT: 47%
Market capitalization -- AKESF: $10.51B vs. SMMT: $15.81B
AKESF [@Biotechnology] is valued at $10.51B. SMMT’s [@Biotechnology] market capitalization is $15.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than AKESF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 2 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • AKESF’s TA Score: 2 bullish, 5 bearish.
  • SMMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than AKESF.

Price Growth

AKESF (@Biotechnology) experienced а -2.42% price change this week, while SMMT (@Biotechnology) price change was +1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($15.8B) has a higher market cap than AKESF($10.5B). SMMT (26.36) and AKESF (25.37) have similar P/E ratio . AKESF YTD gains are higher at: 72.857 vs. SMMT (18.801).
AKESFSMMTAKESF / SMMT
Capitalization10.5B15.8B66%
EBITDAN/A-235.08M-
Gain YTD72.85718.801388%
P/E Ratio25.3726.3696%
RevenueN/A0-
Total CashN/A361M-
Total DebtN/A6.45M-
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKESFSMMT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend about 1 month ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JVAL44.830.60
+1.36%
JPMorgan US Value Factor ETF
DIVO42.720.17
+0.40%
Amplify CWP Enhanced Dividend Income ETF
DGRE27.620.05
+0.18%
WisdomTree Emerging Mkts Qual Div Gr ETF
BSR27.82N/A
N/A
Beacon Selective Risk ETF
LIBD263.22N/A
N/A
LifeX 2065 Inflation-Protected Longevity Income ETF

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
+3.29%
INBX - AKESF
45%
Loosely correlated
+2.80%
SMMT - AKESF
27%
Poorly correlated
-0.38%
NUVL - AKESF
25%
Poorly correlated
+2.24%
BNTX - AKESF
23%
Poorly correlated
+0.98%
CPMV - AKESF
22%
Poorly correlated
N/A
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-0.38%
BCDA - SMMT
70%
Closely correlated
+2.56%
TIL - SMMT
52%
Loosely correlated
+5.28%
BNTX - SMMT
51%
Loosely correlated
+0.98%
RLAY - SMMT
45%
Loosely correlated
+1.73%
VBIZF - SMMT
42%
Loosely correlated
-18.18%
More